Pfizer has issued a "Dear Healthcare Professional" letter to clarify and strengthen contraindications with its antipsychotic agent ziprasidone HCl (Geodon).

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Clarification, strengthening of ziprasidone QTc prolongation warning.

Newsletter